<DOC>
	<DOCNO>NCT01923194</DOCNO>
	<brief_summary>Evaluate Efficacy Safety Highly Purified Urofollitropin Injection Compared Recombinant Human Follitropin Alfa Injection Ovulation Induction Chinese female</brief_summary>
	<brief_title>Evaluation Efficacy Safety Highly Purified Urofollitropin Ovulation Induction Chinese Females</brief_title>
	<detailed_description />
	<mesh_term>Anovulation</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Signed informed consent form prior screening evaluation Chinese female age 2039 year Infertility least 1 year screen Women WHO type II anovulatory infertility chronic anovulation ( define amenorrhoea ( i.e. , menstrual bleed 6 month ) oligoamenorrhoea ( i.e. , cycle 35 day ) ) progestogen induce withdrawal bleed spontaneous menstrual bleeding Failure conceive least one cycle ovulation induction clomiphene citrate Bilateral tubal patency document hysterosalpingography sonohysterography laparoscopy within 2 year prior screen Normal pelvis document transvaginal ultrasound respect uterus , Fallopian tube ovary within 3 month prior screen Early follicular phase serum level FSH within normal limit ( 112 IU/L , ) ( result obtain within 2 month prior randomization ) LH ( Luteinizing hormone ) , prolactin , E2 ( estradiol ) , progesteron , total testosterone , TSH ( thyrotropin ) level within normal limit clinical laboratory Male partner semen analysis obtain within 12 month prior randomisation show acceptable value semen accord local laboratory , show 2.000.000 progressive motile sperm per mL capacitation ( case IUI ( intrauterine insemination ) ) BMI ( Body mass index ) ≥ 18.5 &lt; 30 kg/m2 Any know clinically significant systemic disease Known past current thrombophlebitis thromboembolism include venous thrombosis disease active recent arterial thrombosis disease Any known endocrine metabolic abnormality compromise participation trial exception control thyroid function disease Any know concomitant medication would interfere evaluation study medication . Specifically , nonstudy hormonal therapy ( except thyroid medication ) , antipsychotic , anxiolytic , hypnotic sedative , need continuous use prostaglandin inhibitor ( nonsteroid anti inflammatory drug ( NSAIDs ) , include aspirin ) time study entry . Known history 12 unsuccessful ( pregnancy achieve ) ovulation induction cycle Any known treatment clomiphene citrate , metformin , gonadotropins GnRH analogue within one month prior randomisation Ovarian cyst mean diameter ≥ 15 mm persist one cycle ovarian endometrioma ultrasound Known least one previous cycle experience luteinized unruptured follicle syndrome Known abnormal result cervical examination clinical significance obtain within 1 year prior screen Abnormal vaginal bleeding undetermined origin Known tumor ovary , breast , uterus , adrenal gland , pituitary hypothalamus Known malformation sexual organ incompatible pregnancy Known current past ( last 12 month ) abuse alcohol drug Known history chemotherapy ( except gestational condition ) radiotherapy Finding clinically relevant abnormal laboratory value Use non register investigational drug 3 month screen previous participation study Pregnancy , lactation contraindication pregnancy</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>39 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>